Exzeo Group, Inc. (NASDAQ: XZO) Chief Executive Officer Paresh Patel disclosed a personal purchase of 2,000 shares of common stock on April 13, 2026, according to a Form 4 filed with the Securities and Exchange Commission. The shares were acquired at $15.13 each, bringing the cash outlay for the transaction to $30,260.
Since that purchase, XZO shares have moved to $16.18, representing a near-term increase from the price paid by the CEO. Analysts who follow the company maintain price targets in a range between $25 and $27.
After the acquisition, Patel’s direct holdings in Exzeo Group total 1,610,013 shares. In addition to his common shares, Patel has options to purchase 5,000,000 shares of company stock. Those options were granted on October 1, 2021, carry an exercise price of $23 per share and began vesting in installments beginning October 1, 2022.
The timing of the CEO’s open-market purchase stands out against recent price action: the stock has declined roughly 27% over the past six months but has recovered about 7.5% in the last week. An InvestingPro note cited in company documentation flags that XZO is trading at a relatively low price-to-earnings ratio when compared with near-term earnings growth expectations, and reports a PEG ratio of 0.15. The same service references a comprehensive Pro Research Report that covers XZO along with more than 1,400 other U.S. equities for investors seeking deeper analysis.
Separately, Exzeo Group reported fourth-quarter and full-year 2025 results that met analysts’ expectations. The company posted a diluted earnings per share of $0.25 and reported quarterly revenue of $53.32 million. Market reaction to the earnings announcement included an uptick in investor optimism and a rise in aftermarket trading. The company did not report any changes in analyst ratings or release additional company-specific news in connection with those results.
Key points
- CEO Paresh Patel purchased 2,000 shares on April 13, 2026, at $15.13 per share, totaling $30,260.
- Patel now directly owns 1,610,013 shares and holds options on 5,000,000 additional shares, granted October 1, 2021, at a $23 exercise price with vesting beginning October 1, 2022.
- Exzeo’s fourth-quarter and full-year 2025 results matched forecasts: diluted EPS of $0.25 and quarterly revenue of $53.32 million; the stock has risen to $16.18 post-purchase and faces analyst targets of $25 to $27.
Risks and uncertainties
- The company’s share price has fallen about 27% over the prior six months, indicating potential volatility in the stock that could affect investor returns.
- Although quarterly results met analysts’ forecasts, there were no reported upgrades to analyst ratings or additional company guidance that might clarify future expectations.
- Patel’s outstanding options have an exercise price of $23, above the recent trading levels noted here, which creates uncertainty around the timing and economic benefit of those options depending on future share performance.
This article presents the transaction and recent financial disclosures as reported in regulatory filings and company announcements. It does not include commentary beyond the facts provided in those filings and reports.